clinivation, Inc. - Headlines

With comprehensive performance metrics, the clinivation Global xi Market Clearance Platform leverages operational excellence to advance new worldwide revenue and achieve new milestones of enterprise value.

Natick, MA, September 20, 2010 - clinivation, Inc. announced today the release of new, comprehensive performance management components for the Global xi Market Clearance Platform.

"Effective execution of worldwide submissions and approvals requires comprehensive performance management components that legacy tracking tools, home-grown databases, and spreadsheet farms can't deliver," said Joseph Kozikowski, M.D., clinivation's Founder, Chairman, and Chief Executive Officer. "Indeed, new market clearance processes are proliferating worldwide- creating new complexities of execution for each team, market, region, and product class," he continued.

The clinivation Global xi Market Clearance Platform addresses these challenges by providing executive management and teams with full visibility on the process, status, and forecast of their entire global market clearance operations.

Interactive dashboards enable immediate drill-down into comprehensive Key Performance Indicators and forecasts, and libraries of user-configurable reports support enterprise-wide planning, control, and communications.

"Manually-prepared status reports are slow. And being of limited scope, they often raise more questions than they answer. Clinivation Global xi now delivers the comprehensive performance metrics and management tools that leverage operational excellence into the achievement of market clearance goals, new worldwide revenue, and new milestones of corporate value," he continued.

The clinivation Global xi enterprise solution for Market Clearance Management enables executives and their teams to address the challenges of execution, effective governance, and lean business performance in their global market clearance operations. By enabling excellence in global market clearance operations to advance the revenue intrinsic to market clearance success, clinivation Global xi liberates revenue that's trapped-in-process.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global xi market clearance platform, clinivation WorldView on-demand regulatory intelligence, and clinivation Clinical Suite and clinivation Registry Suite electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com